WASHINGTON, DC – Today, U.S. Senator Jacky Rosen (D-NV) announced that a law she helped pass has led to lower prices for 15 additional medications for seniors on Medicare Part D. Thanks to the Inflation Reduction Act, Medicare now has the authority to negotiate prescription drug prices directly with pharmaceutical companies. These 15 new drugs are in addition to the ten prescription drugs that have already been negotiated under this authority, with lowered prices set to go into effect in 2026. The new drugs selected for price negotiations include:
“As Nevadans continue being squeezed by rising costs, I’m happy to announce that I helped secure additional lower prescription drug prices for our seniors,” said Senator Rosen. “After passing the law to give Medicare the power to negotiate for lower costs, 15 additional medications will see their prices go down. As long as I’m in the Senate, I’ll keep fighting to give Nevadans more breathing room.”
Senator Rosen has been a leader in helping lower medical costs for Nevada’s seniors. Earlier this year, Rosen and Senator John Cornyn (R-TX) introduced the bipartisan Reducing Drug Prices for Seniors Act, which would also help directly reduce out-of-pocket costs for medications for seniors on Medicare. Last year, Rosen helped pass the bill that gave Medicare the power to negotiate for lower prescription drugs and cap the price of insulin at $35 a month. At the beginning of this year, Senator Rosen announced the start of a cap on prescription drug prices for Nevada seniors that she helped pass.
###
